×
戻る Agendas
Session 4: Special Product Areas
Session Chair(s)
Rebecca Noel, DrPH, MPH
Executive Director, Benefit-Risk Assessment
Eli Lilly, United States
Session 4: Special Product Areas
Speaker(s)
Medical Devices and Combination Products - Industry Perspective
Marc-Andre Cote
Cote Regulatory Affairs, United States
OTC and Natural Health Products
Stephanie Jack, MSC
Health Canada, Canada
Scientific Manager
A Perspective from the Generics
Colin D'Cunha, MD, MHS, FRCPC
Apotex Inc., Canada
Director, Global Medical Affairs